• RSL3: GPX4 Inhibitor for Precision Ferroptosis in Cancer ...

  2026-02-07

  RSL3 stands out as a potent and selective GPX4 inhibitor, empowering cancer researchers to induce ferroptosis with unprecedented specificity and efficiency. Its robust performance in both in vitro and in vivo systems makes it a cornerstone for dissecting iron-dependent, ROS-mediated cell death, especially in RAS-driven tumor models.

• Morin: Beyond Antioxidant—Mechanistic Insights for Neurol...

  2026-02-06

  Explore Morin, a natural flavonoid antioxidant, as a neuroprotective and cardioprotective compound with unique mechanisms relevant to neurodegenerative and metabolic disease models. This article delivers advanced analysis on Morin's impact on mitochondrial energy metabolism and its role as a fluorescent aluminum ion probe.

• Parathyroid hormone (1-34) (human): Pushing Boundaries in...

  2026-02-06

  Explore the advanced applications of Parathyroid hormone (1-34) (human) as a parathyroid hormone 1 receptor agonist and calcium homeostasis regulator. This article uniquely integrates molecular mechanisms, high-fidelity disease modeling, and the latest advances in kidney assembloid research.

• RSL3 and the Ferroptosis Signaling Pathway: Precision Too...

  2026-02-05

  Explore how RSL3, a potent glutathione peroxidase 4 inhibitor, enables precise modulation of oxidative stress and ferroptosis signaling in cancer research. This article uniquely focuses on the mechanistic interplay between RSL3, ROS-mediated non-apoptotic cell death, and oncogenic RAS synthetic lethality, offering advanced insights for translational applications.

• Morin (C5297): Natural Flavonoid Antioxidant & Mitochondr...

  2026-02-05

  Morin, a natural flavonoid antioxidant, is a validated mitochondrial energy metabolism modulator with potent inhibition of adenosine 5′-monophosphate deaminase. Supplied by APExBIO, it is widely researched for its anti-inflammatory, cardioprotective, and neuroprotective effects in diabetes and neurodegenerative models.

• Morin: A Multifunctional Flavonoid for Mitochondrial Ener...

  2026-02-04

  Explore the advanced applications of Morin, a natural flavonoid antioxidant, as a mitochondrial energy metabolism modulator and fluorescent aluminum ion probe. This article delivers a mechanistic deep dive and highlights Morin’s unique role in translational disease research.

• RSL3: Benchmark GPX4 Inhibitor for Ferroptosis in Cancer ...

  2026-02-04

  RSL3's high selectivity for glutathione peroxidase 4 (GPX4) positions it as a gold-standard ferroptosis inducer in cancer research, enabling robust dissection of redox vulnerabilities and iron-dependent cell death mechanisms. This guide delivers actionable protocols, advanced applications, and troubleshooting insights for leveraging RSL3 in experimental and translational settings.

• RSL3 and GPX4 Inhibition: Unlocking Ferroptosis for Preci...

  2026-02-03

  Explore how RSL3, a potent glutathione peroxidase 4 inhibitor, enables precise modulation of ferroptosis and oxidative stress in cancer biology. Gain advanced insight into molecular mechanisms, translational opportunities, and the latest research linking m6A RNA modifications and GPX4 regulation.

• Reimagining Translational Research: Parathyroid Hormone (...

  2026-02-03

  This thought-leadership article explores the transformative potential of Parathyroid hormone (1-34) (human) in advancing research on calcium regulation, bone metabolism, and next-generation kidney organoid models. Blending mechanistic insight with strategic guidance, it contextualizes APExBIO’s high-purity PTH (1-34) peptide fragment within current competitive and translational landscapes, drawing on cutting-edge findings and highlighting new opportunities for translational researchers.

• Morin (C5297): Scenario-Based Solutions for Reliable Cell...

  2026-02-02

  This article guides biomedical researchers through real-world laboratory challenges and demonstrates how Morin (SKU C5297) addresses key issues in cell viability, proliferation, and cytotoxicity assays. Drawing on scenario-driven Q&A and evidence-based insights, it highlights Morin's reproducibility, mechanistic strengths, and practical optimization tips for demanding workflows.

• Parathyroid hormone (1-34) (human): Atomic Mechanistic In...

  2026-02-02

  Parathyroid hormone (1-34) (human) is a validated parathyroid hormone 1 receptor agonist and calcium homeostasis regulator. Its precise molecular activity and robust in vivo benchmarks make it a gold-standard tool for bone metabolism and advanced kidney disease modeling.

• RSL3: GPX4 Inhibitor for Ferroptosis Induction in Cancer ...

  2026-02-01

  RSL3, a highly selective glutathione peroxidase 4 (GPX4) inhibitor, is a validated ferroptosis inducer central to oxidative stress and cancer biology research. By disrupting redox balance, RSL3 enables precise studies of iron-dependent, non-apoptotic cell death pathways. Its robust activity, including synthetic lethality in RAS-mutant cells, underpins its utility in translational models and mechanistic studies.

• Parathyroid hormone (1-34) (human): Precision Modulator f...

  2026-01-31

  Explore the advanced mechanisms and emerging applications of Parathyroid hormone (1-34) (human) in bone metabolism and kidney disease modeling. This in-depth analysis reveals how PTH (1-34) peptide fragment drives next-generation research through unique cAMP signaling and calcium homeostasis regulation.

• Parathyroid hormone (1-34) (human): Unraveling Mechanisti...

  2026-01-30

  Explore the advanced mechanistic roles of Parathyroid hormone (1-34) (human) as a parathyroid hormone 1 receptor agonist and calcium homeostasis regulator. This deep-dive article reveals novel insights into PTH (1-34) peptide fragment signaling, in vivo modeling, and the future of bone and kidney research.

• Unlocking Translational Potential: Mechanistic and Strate...

  2026-01-30

  This thought-leadership article unpacks the mechanistic insights and strategic opportunities of SU 5402, a potent receptor tyrosine kinase inhibitor from APExBIO. By bridging oncology and neurovirology, and integrating advanced iPSC-derived neuronal models, we illustrate how SU 5402 empowers translational researchers to design high-impact studies, validate disease mechanisms, and accelerate therapeutic innovation. Drawing on recent literature—including validated human sensory neuron models for HSV-1 research—this piece provides a roadmap for leveraging SU 5402 in next-generation workflows while expanding beyond conventional product discourse.

15116 records 1/1008 page Next 12345 下5页 Last page